LSE:DPH (Dechra Pharmaceuticals Plc)

About DPH

Dechra Pharmaceuticals PLC is a holding company, which engages in the veterinary pharmaceuticals and related products business. It operates through the following segments: European Pharmaceuticals; North American Pharmaceuticals; and Pharmaceuticals Research and Development. The European Pharmaceuticals segment markets and sells licensed pharmaceuticals and specialist pet foods to the veterinary profession in Europe. The North American Pharmaceuticals segment focuses on the sale of a range of endocrine, ophthalmic, dermatological, and equine products in North America. The Pharmaceuticals Research and Development segment develops and licenses Dechra's own branded veterinary product portfolio of novel and generic pharmaceuticals and specialist pet diets. The company was founded in 1819 and is headquartered in Northwich, the United Kingdom.

Dechra Pharmaceuticals Plc (LSE: DPH) Latest News

Investing Articles

Are GlaxoSmithKline plc, Dechra Pharmaceuticals plc & CareTech Holdings plc On The Cusp Of Stunning Returns?

Could these 3 healthcare stocks transform your portfolio? GlaxoSmithKline plc (LON: GSK), Dechra Pharmaceuticals plc (LON: DPH) and CareTech Holdings…

Read more »

Investing Articles

4 Great Growth Picks For 2016 And Beyond: Barclays PLC, Dechra Pharmaceuticals plc, Britvic Plc And Marks & Spencer Group Plc

Royston Wild analyses the growth potential of Barclays PLC (LON: BARC), Dechra Pharmaceuticals plc (LON: DPH), Britvic Plc (LON: BVIC)…

Read more »

Investing Articles

Are AstraZeneca plc, Indivior PLC & Dechra Pharmaceuticals plc Set To Double by 2016?

AstraZeneca plc (LON:AZN), Indivior PLC (LON:INDV) and Dechra Pharmaceuticals plc (LON:DPH) offer three very different risk profiles, argues Alessandro Pasetti.

Read more »

Investing Articles

Why AstraZeneca plc, Dechra Pharmaceuticals plc And Tissue Regenix Group PLC Are A Perfect Healthcare Combination

AstraZeneca plc (LON:AZN), Dechra Pharmaceuticals plc (LON:DPH) and Tissue Regenix Group PLC (LON:TRX) are a terrific trio to buy today.

Read more »

Investing Articles

Why Now Is The Perfect Time For Me To Buy GlaxoSmithKline plc And Dechra Pharmaceuticals plc

These 2 stocks look set to post stunning gains: GlaxoSmithKline plc (LON: GSK) and Dechra Pharmaceuticals plc (LON: DPH)

Read more »

Investing Articles

Why I’d Buy GlaxoSmithKline plc Before Dechra Pharmaceuticals plc Or Al Noor Hospitals Group PLC

GlaxoSmithKline plc (LON: GSK) could outperform Dechra Pharmaceuticals plc (LON: DPH) and Al Noor Hospitals Group PLC (LON: ANH)

Read more »

Investing Articles

Is AstraZeneca plc A Better Buy Than BTG plc, Dechra Pharmaceuticals plc And Genus plc?

How does AstraZeneca plc (LON: AZN) stack up against three pharmaceutical peers: BTG plc (LON: BTG), Dechra Pharmaceuticals plc (LON:…

Read more »

Investing Articles

Are Genus plc And Dechra Pharmaceuticals plc Better Buys Than GlaxoSmithKline plc?

Which of these 3 pharmaceutical companies should you add to your portfolio? Genus plc (LON: GNS), Dechra Pharmaceuticals plc (LON:…

Read more »

Investing Articles

3 Fast-Growing Pharmaceuticals Set To Outperform: Shire PLC, BTG plc and Dechra Pharmaceuticals plc

Shire PLC (LON:SHP), BTG plc (LON:BTG) and Dechra Pharmaceuticals plc (LON:DPH) could boost your 2015 returns

Read more »

Investing Articles

3 FTSE Dividends Lifted This Week: Hargreaves Lansdown PLC, Dechra Pharmaceuticals plc And Staffline Group Plc

Hargeaves Lansdown PLC (LSE: HL), Dechra Pharmaceuticals plc (LON: DPH) and Staffline Group Plc (LON: STAF) raise their payments.

Read more »

Investing Articles

Why Punch Taverns plc (LON: PUB), Greene King plc (LON: GNK) and Dechra Pharmaceuticals plc Should Beat The FTSE 100 Today

Punch Taverns plc (LON: PUB), Greene King plc (LON: GNK) and Dechra Pharmaceuticals plc (LON: DPH) are on the up.

Read more »

Company Comment

Dechra Pharmaceuticals Plc Sells Pet Wholesale Business To Patterson Companies, Inc

Dechra Pharmaceuticals plc (LON:DPH) fails to meet the market's expectations in a trading update, and sells its oldest division to…

Read more »